SARS-CoV-2 infection: The role of cytokines in COVID-19 disease

被引：746

作者：

Costela-Ruiz, Victor J. ^{[1
,2
]}

Illescas-Montes, Rebeca ^{[1
,2
]}

Puerta-Puerta, Jose M. ^{[3
]}

Ruiz, Concepcion ^{[1
,2
,4
]}

Melguizo-Rodriguez, Lucia ^{[1
,2
]}

机构：

[1] Univ Granada, Fac Hlth Sci, Dept Nursing, Biomed Grp BIO277, Avda Ilustrac 60, Granada 18016, Spain

[2] Ibs Granada, Inst Biosanit Res, C Doctor Asspitarte 4,4a Planta, Granada 18012, Spain

[3] Univ Hosp Virgen de las Nieves, Hematol & Hemotherapy Unit, Granada, Spain

[4] Univ Granada, Inst Neurosci, Ctr Invest Biomed CIBM, Parque Tecnol Salud PTS Avda Conocimiento S-N, Granada 18016, Spain

来源：

CYTOKINE & GROWTH FACTOR REVIEWS | 2020年 / 54卷

关键词：

COVID-19; SARS-CoV-2; Chemokines; Growth factors; Cytokine storm; COLONY-STIMULATING FACTOR; MESSENGER-RNA EXPRESSION; SARS-CORONAVIRUS; GM-CSF; INTERFERON-GAMMA; DENDRITIC CELLS; INTERLEUKIN-3; IL-3; FETAL MONOCYTES; VIRAL-INFECTION; GROWTH-FACTOR;

D O I：

10.1016/j.cytogfr.2020.06.001

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

COVID-19 disease, caused by infection with SARS-CoV-2, is related to a series of physiopathological mechanisms that mobilize a wide variety of biomolecules, mainly immunological in nature. In the most severe cases, the prognosis can be markedly worsened by the hyperproduction of mainly proinflammatory cytokines, such as IL-1, IL-6, IL-12, IFN-gamma, and TNF-alpha, preferentially targeting lung tissue. This study reviews published data on alterations in the expression of different cytokines in patients with COVID-19 who require admission to an intensive care unit. Data on the implication of cytokines in this disease and their effect on outcomes will support the design of more effective approaches to the management of COVID-19.

引用

页码：62 / 75

页数：14

共 50 条

[21] The Pathophysiology of COVID-19 and SARS-CoV-2 Infection Reply
Oning, Dieter B.
Bloch, Wilhelm
Kuebler, Wolfgang M.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2021, 321 (03) : L638 - L639
[22] Role of cholesterol in COVID-19 disease and in the SARS-CoV-2 spike interaction
Kocar, E.
Skubic, C.
Ivanusa, P.
Brzin, J.
Rezen, T.
Turel, G.
Bogovic, P.
Strle, F.
Rozman, D.
FEBS OPEN BIO, 2021, 11 : 504 - 504
[23] SARS-CoV-2 and COVID-19
Sheng, Wang-Huei
Ko, Wen-Chien
Huang, Yhu-Chering
Hsueh, Po-Ren
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2020, 53 (03) : 363 - 364
[24] Impact of Chronic HIV Infection on SARS-CoV-2 Infection, COVID-19 Disease and Vaccines
Yang, Yexin
Iwasaki, Akiko
CURRENT HIV/AIDS REPORTS, 2022, 19 (01) : 5 - 16
[25] Impact of Chronic HIV Infection on SARS-CoV-2 Infection, COVID-19 Disease and Vaccines
Yexin Yang
Akiko Iwasaki
Current HIV/AIDS Reports, 2022, 19 : 5 - 16
[26] COVID-19 and kidney: role of SARS-CoV-2 infection in the induction of renal damage
Perrotta, A. M.
Rotondi, S.
Mazzaferro, S.
Bosi, L.
Letizia, C.
Muscaritoli, M.
Gigante, A.
Salciccia, S.
Pasculli, P.
Ciardi, M. R.
Tinti, F.
Galani, A.
Errigo, F.
Mene, P.
Cianci, R.
Mitterhofer, A. P.
Mastroianni, C. M.
Palange, P.
Lai, S.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (16) : 7861 - 7867
[27] ACEing COVID-19 A Role for Angiotensin Axis Inhibition in SARS-CoV-2 Infection?
Murthy, Venkatesh L.
Koupenova, Milka
Shah, Ravi V.
CIRCULATION RESEARCH, 2020, 126 (12) : 1682 - 1684
[28] The role of epidemiologists in SARS-CoV-2 and COVID-19 research
Oremus, M.
Taylor-Wilson, R.
Aldrich, M.
Bell, K.
Gaudino, J.
Palevsky, S.
Payne, J.
Raynes-Greenow, C.
Sim, F.
Smith, M.
Weiss, S.
Zhang, Y.
PUBLIC HEALTH, 2021, 190 : E3 - E4
[29] Role of COVID-19 Vaccines in SARS-CoV-2 Variants
Zhou, Zhou
Zhu, Yimiao
Chu, Ming
FRONTIERS IN IMMUNOLOGY, 2022, 13
[30] Thrombotic microangiopathy: A renal manifestation in SARS-CoV-2 infection (COVID-19 disease)
Marcilla Vazquez, Carlos
Vidal Company, Alberto
Navarro Felipe, Anabel
Alfaro Ponce, Blanca
ANALES DE PEDIATRIA, 2020, 93 (05): : 352 - 353

← 1 2 3 4 5 →